CLINICAL_TRIALS
trial_result
· 2018-09-06
Clinical Trial Update: US Phase III Study of APD421 in PONV [Phase 3]
Summary
The Phase 3 US study of APD421 for postoperative nausea and vomiting has completed. Trial results were posted on 2018-09-06.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Acacia Pharma Ltd | Conditions: PONV | Phase 3 | Status: COMPLETED | Results posted: 2018-09-06